Explainable AI for Predicting Hospital Admissions in Heart Failure: ExplAIn-HF
- Sponsor
- Medisch Spectrum Twente
- Study ID
- NCT07689760
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are: 1. To develop and validate an XAI based model that predicts HF events and identifies modifiable contributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care. In the Netherlands usual care includes remote monitoring of heartrate, blood pressure, weight and symptoms. 2. To include insights of the smartwatch into activity patterns, impact on quality of life (KCCQ-12), and patient satisfaction with net promoter score (NPS). Participants will wear a smartwatch for six months and perform an I-lead ecg with the smartwatch weekly.
Key Dates
- First listed
- Jul 8, 2026
- Start date
- Jul 31, 2026
- Status verified
- Jun 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 95 participants (estimated)
Arms
- Arm: Heart failure patients
Primary Outcome Measure
Heart failure (HF) event [ Time Frame: From enrollment to the end of follow-up at 6 months ]
Central Contacts
- Mark Schuuring, M.D., PhD., FESC, FEACVI, FHFA0534872105
Find similar trials
Related Studies
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsRecruiting · Medtronic · Birmingham, Alabama
- Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart FailureRecruiting · UConn Health · Farmington, Connecticut
- Identification of Genomic Predictors of Adverse Events After Cardiac SurgeryRecruiting · Brigham and Women's Hospital · Dallas, Texas
- Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft TissuesRecruiting · Arunark Kolipaka · Columbus, Ohio